Substrate Oxidation in Children in Response to High and Low Dairy Intake

NCT01664702 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2012-08-14

No results posted yet for this study

Summary

The investigators propose a randomized trial comparing higher levels of dairy intake compared to lower levels of dairy intake. Participants will be 20 boys and girls, age 10-13, overweight (\>85%) who are currently consuming 1 or fewer servings of dairy per day. Each participant will be randomized to either higher or lower levels of dairy intake. A baseline calorimeter stay will determine 24-hour energy needs. Participants will then receive the diet they have been randomized to receive for 6 days and will then have a second calorimeter stay. During this 2nd stay, each participant will continue to receive the diet they were randomized to receive and will achieve a 300 kcal energy deficit through physical activity. The investigators hypothesize that children who receive a 300 kcal energy deficit from the energy expenditure of exercise and receive 3 to 4 servings of dairy products will show greater increases in fat oxidation compared to children who receive a 300 kcal energy expenditure of exercise and receive 1 or fewer servings of dairy products.

Conditions

  • Childhood Obesity

Interventions

DIETARY_SUPPLEMENT

Dairy Products

See the effect dairy product has on fat oxidation in overweight individuals expending the same amount of energy

DIETARY_SUPPLEMENT

Dairy Servings

Continue baseline consumption of one or fewer servings of dairy per day

Sponsors & Collaborators

  • Dairy Management Inc.

    collaborator INDUSTRY
  • University of Kansas

    lead OTHER

Principal Investigators

  • Joseph E Donnelly, EdD · Univesity of Kansas

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
10 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2005-12-31
Completion
2005-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01664702 on ClinicalTrials.gov